Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro R Lowenstein

Showing results (51-60 of 199) with videos related to

Pageof 20
Sort By:
Molecular Cancer Therapeutics|March 19, 2008
Turning the gene tap off; implications of regulating gene expression for cancer therapeuticsJames F Curtin, Marianela Candolfi, Weidong Xiong, et al.
Journal of Virology|March 9, 2002
Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell typesClare E Thomas, Penny Edwards, Thomas J Wickham, et al.
Current Gene Therapy|November 6, 2007
Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactionsPedro R Lowenstein, Ronald J Mandel, Wei-Dong Xiong, et al.
Oncotarget|January 5, 2021
Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomasSyed M Faisal, Flor M Mendez, Fernando Nunez, et al.
STAR Protocols|May 31, 2022
Murine brain tumor microenvironment immunophenotyping using mass cytometryBrandon L McClellan, Mahmoud S Alghamri, Rohit Thalla, et al.
Neuroscience Letters|August 22, 2012
Gene therapy for brain tumors: basic developments and clinical implementationHikmat Assi, Marianela Candolfi, Gregory Baker, et al.
Oncotarget|August 27, 2016
Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discovery toolThomas J Wilson, Daniel B Zamler, Robert Doherty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
In vivo polarization of IFN-gamma at Kupfer and non-Kupfer immunological synapses during the clearance of virally infected brain cellsCarlos Barcia, Kolja Wawrowsky, Robert J Barrett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2003
Adenovirus expression of IL-1 and NF-kappaB inhibitors does not inhibit acute adenoviral-induced brain inflammation, but delays immune system-mediated elimination of transgene expressionDaniel Stone, Weidong Xiong, Judith C Williams, et al.
Current Gene Therapy|February 7, 2006
Gene therapy and targeted toxins for gliomaGwendalyn D King, James F Curtin, Marianela Candolfi, et al.
Pageof 20

Showing results (51-60 of 199) with videos related to

Sort By:
Pageof 20
Molecular Cancer Therapeutics|March 19, 2008
Turning the gene tap off; implications of regulating gene expression for cancer therapeuticsJames F Curtin, Marianela Candolfi, Weidong Xiong, et al.
Journal of Virology|March 9, 2002
Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell typesClare E Thomas, Penny Edwards, Thomas J Wickham, et al.
Current Gene Therapy|November 6, 2007
Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactionsPedro R Lowenstein, Ronald J Mandel, Wei-Dong Xiong, et al.
Oncotarget|January 5, 2021
Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomasSyed M Faisal, Flor M Mendez, Fernando Nunez, et al.
STAR Protocols|May 31, 2022
Murine brain tumor microenvironment immunophenotyping using mass cytometryBrandon L McClellan, Mahmoud S Alghamri, Rohit Thalla, et al.
Neuroscience Letters|August 22, 2012
Gene therapy for brain tumors: basic developments and clinical implementationHikmat Assi, Marianela Candolfi, Gregory Baker, et al.
Oncotarget|August 27, 2016
Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discovery toolThomas J Wilson, Daniel B Zamler, Robert Doherty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
In vivo polarization of IFN-gamma at Kupfer and non-Kupfer immunological synapses during the clearance of virally infected brain cellsCarlos Barcia, Kolja Wawrowsky, Robert J Barrett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2003
Adenovirus expression of IL-1 and NF-kappaB inhibitors does not inhibit acute adenoviral-induced brain inflammation, but delays immune system-mediated elimination of transgene expressionDaniel Stone, Weidong Xiong, Judith C Williams, et al.
Current Gene Therapy|February 7, 2006
Gene therapy and targeted toxins for gliomaGwendalyn D King, James F Curtin, Marianela Candolfi, et al.
Pageof 20